Difference between revisions of "COVID-19 and emerging viral infections: The case for interferon lambda (DOI: 10.1084/jem.20200653) (Q10304)"
Jump to navigation
Jump to search
(Added reference to claim: Author (P97): Dickenson RE (3rd author of DOI: 10.1084/jem.20200653) (Q10307), #quickstatements; #temporary_batch_1592857754139) |
(Created claim: Author (P97): Durbin JE (4th author of DOI: 10.1084/jem.20200653) (Q10308), #quickstatements; #temporary_batch_1592857754139) |
||
Property / Author | |||
+ | |||
Property / Author: Durbin JE (4th author of DOI: 10.1084/jem.20200653) / rank | |||
+ | Normal rank |
Revision as of 20:29, 22 June 2020
Research article published in J. Exp. Med.; 2020 05 04 ; 217 (5)
Language | Label | Description | Also known as |
---|---|---|---|
English |
COVID-19 and emerging viral infections: The case for interferon lambda (DOI: 10.1084/jem.20200653)
|
Research article published in J. Exp. Med.; 2020 05 04 ; 217 (5)
|
Statements
J. Exp. Med.; 2020 05 04 ; 217 (5).
COVID-19 and emerging viral infections: The case for interferon lambda (English)